Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats

Mi Hyeon Hong; Jin Seok Hwang; Byung Hyuk Han; Yun Jung Lee; Jung Joo Yoon; Chang Seob Seo; Dae Gill Kang; Hye Yoom Kim; Ho Sub Lee

doi:10.1155/2021/8443952

Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats

Evid Based Complement Alternat Med. 2021 Dec 17:2021:8443952. doi: 10.1155/2021/8443952. eCollection 2021.

Authors

Mi Hyeon Hong^{1

2}, Jin Seok Hwang¹, Byung Hyuk Han^{1

2}, Yun Jung Lee^{1

2}, Jung Joo Yoon^{1

2}, Chang Seob Seo³, Dae Gill Kang^{1

2}, Hye Yoom Kim^{1

2}, Ho Sub Lee^{1

2}

Affiliations

¹ College of Oriental Medicine and Professional Graduate School of Oriental Medicine, Wonkwang University, 54538 Iksan, Republic of Korea.
² Hanbang Cardio-Renal Syndrome Research Center, Wonkwang University, 54538 Iksan, Republic of Korea.
³ KM Science Research Division, Korea Institute of Oriental Medicine, 34054 Daejeon, Republic of Korea.

Abstract

Samchulkunbi-tang (SCT, Shen Zhu Jian pi tang in Chinese) is said to have been first recorded by Zheng Zhi Zhun Sheng during the Ming Dynasty in China. Records of SCT in Korea are known to have been cited in Donguibogam (Dong Yi Bao Jian in Chinese), Uibang Hwaltu (Yi Fang Huo Tao in Chinese), and Bang Yak Hapyeon (Fang Yao He Bian in China). Although SCT is widely used in treating chronic gastritis and gastric ulcers, the beneficial effect on renal vascular function is unknown. Hypertension is a risk factor for cardiovascular disease and endothelial dysfunction in humans and experimental animal models of arterial hypertension. In addition, kidney dysfunction is characterized by hypertension diseases. This study was conducted to evaluate the effect of SCT on the vascular function in vitro (human umbilical cord endothelial cells, HUVECs) and in vivo (N^G-nitro-L-arginine methyl ester, L-NAME-induced hypertensive rats). The phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) is closely related to nitric oxide (NO) production in HUVECs, and SCT in this study significantly increased these. For three weeks, hypertensive rat models were induced by L-NAME administration (40 mg/kg/day) with portable water. It was followed by oral administration with 100 and 200 mg/kg/day for two weeks to confirm the effectiveness of SCT. As a result, systolic blood pressure decreased in the SCT-treated groups, compared with that in the L-NAME-induced hypertensive group. SCT treatment restored vasorelaxation by stimulating acetylcholine and cGMP production in the thoracic aorta. In addition, SCT treatment decreased intima-media thickness, attenuated the reduction of eNOS expression, and increased endothelin-1 expression. It also increased p-Akt and p-eNOS expression in hypertensive rat aorta. Furthermore, regarding renal function parameters, SCT ameliorated urine osmolality, urine albumin level, serum creatinine, and blood urea nitrogen levels. These results demonstrate that the oriental medicine SCT exerts potent vascular and renal protective effects on nitric oxide-deficient hypertensive rats and HUVECs.